SecBot SecBot
Insider Cluster (2 insiders) ·Filed May 8, 2026

PTGX

Protagonist Therapeutics, Inc
NEUTRAL
Impact 4/10
Horizondays Processed6mo ago
Insider cluster: 2 insiders, $8.1M total
Actionable Insight • Neutral

The CEO's sale is a textbook cashless exercise pattern (option exercise + immediate sale to cover taxes and realize gains) following a 364% stock appreciation from the $21.58 strike. At 0.12% of market cap, this cluster is too small to signal fundamental concern. The Q1 earnings beat and $200M rusfertide milestone are the dominant catalysts. Monitor for any secondary offerings or insider sales exceeding 0.5% of market cap in the next 30 days.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$99.36
T+0 close · May 7, 2026 · via day close
Latest settled
+36.68%
T+60 · $135.81
Vs SPY
+31.85%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 8 $99.36entry
  2. T+1 · 6mo ago +4.17%α +3.93% · $103.50
  3. T+5 · 6mo ago +6.23%α +4.77% · $105.55
  4. T+20 · 5mo ago −1.99%α −2.02% · $97.38
  5. T+60 · 3mo ago +36.68%α +31.85% · $135.81
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Protagonist Therapeutics CEO Dinesh Patel sold $7.5M worth of stock on May 12, 2026, following a $600K sale by Director Bryan Giraudo on May 8, creating a two-insider sell cluster totaling $8.11M. The sales occurred just 9 days after a massive Q1 earnings beat (revenue $56.4M vs $16.3M consensus, EPS $0.05 vs -$0.65 consensus) driven by milestone payments from ICOTYDE FDA approval and the rusfertide opt-out. While the earnings beat is clearly positive, the CEO's large open-market sale immediately after exercising options at $21.58/share (realizing ~$7.5M profit) is a routine cashless exercise pattern, the stock is up ~364% from the option strike, and the sale represents only ~0.12% of the $6.7B market cap, falling below the 0.5% materiality threshold.

Key Financial Metrics

Direction
selling
Total Value
$8.1M
Insiders
2

Key Facts

  • CEO Dinesh Patel sold 75,000 shares at $100.12 for $7.51M on May 12, 2026, after exercising options at $21.58/share
  • Director Bryan Giraudo sold 6,000 shares at $100.00 for $600K on May 8, 2026
  • Total cluster value: $8.11M, representing ~0.12% of PTGX's $6.7B market cap
  • Sales occurred 9 days after Q1 2026 earnings beat: revenue $56.4M vs $16.3M consensus, EPS $0.05 vs -$0.65 consensus
  • CEO's option exercises were non-cash (A/F) or at $21.58 strike, the $7.5M sale is a standard cashless exercise pattern, not a bearish signal
  • Prior 30-day insider activity showed 4 sells totaling $19.2M, consistent with routine post-vesting diversification

Financial Impact

Total insider sales of $8.11M represent ~0.12% of $6.7B market cap, well below the 0.5% materiality threshold for significant insider selling

insider ownershipdilution

Risk Factors

  • CEO sold 100% of the exercised shares, no retention signals confidence beyond the option exercise itself
  • Stock is up significantly post-earnings; additional insider sales could emerge as lockups expire
  • The $200M rusfertide payment is a one-time event, future quarters will need to show recurring revenue from ICOTYDE sales

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (19 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PTGX-1778803638393

Track record

11 reports on PTGX

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +31.42% at T+60 after the May 5, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 5, 202611d ago 8-K Bullish 7/10 Entry $132.04 Now $124.83 −5.46% settles Feb 4
  2. Nov 4, 202612d ago Institutional Cluster Mixed 3/10 Entry $143.37 Now $124.83 −12.93% settles Feb 2
  3. Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $142.14 Now $124.83 −12.18% settles Jan 26
  4. Aug 10, 202614w ago 144 Bearish 5/10 Entry $148.29 to $143.37 Now $124.83 +15.82% ▲ +3.32% +2.83% vs SPY
  5. Jun 18, 202621w ago 8-K Neutral 3/10 Entry $115.03 to $143.40 Now $124.83 +8.52% ▲ +24.66% +22.92% vs SPY
  6. Jun 12, 202622w ago Institutional Cluster Mixed 5/10 Entry $109.78 to $145.94 Now $124.83 +13.71% ▲ +32.94% +29.67% vs SPY
  7. May 12, 202626w ago 144 Bearish 5/10 Entry $103.88 to $145.87 Now $124.83 −20.17% ▼ −40.42% −35.98% vs SPY
  8. May 8, 202627w ago Insider Cluster Neutral 4/10 Viewing Entry $99.36 to $135.81 Now $124.83 +25.63% ▲ +36.68% +31.85% vs SPY
  9. May 8, 202627w ago Insider Cluster Neutral 5/10 Entry $99.36 to $135.81 Now $124.83 +25.63% ▲ +36.68% +31.85% vs SPY
  10. May 5, 202627w ago 8-K Bullish 7/10 Entry $103.97 to $136.64 Now $124.83 +20.06% ▲ +31.42% +29.36% vs SPY
Showing 10 of 11

US Market Status

Market Closed · Opens in 6h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 14, 2026